Spyre Therapeutics
SYRE
SYRE
78 hedge funds and large institutions have $286M invested in Spyre Therapeutics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 84 → 78 (-6)
13% less capital invested
Capital invested by funds: $328M → $286M (-$42.8M)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
78
Holding in Top 10
3
Calls
$316K
Puts
$104K
Top Buyers
| 1 | +$5.06M | |
| 2 | +$2.76M | |
| 3 | +$2.38M | |
| 4 |
Millennium Management
New York
|
+$1.2M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$934K |
Top Sellers
| 1 | -$7.17M | |
| 2 | -$3.76M | |
| 3 | -$1.72M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$1.39M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$906K |